ConductScience.org, home

Paper41245709

Adjuvant injection therapies following knee cartilage repair demonstrate heterogeneous evidence: A systematic review.

Saráchaga Mendoza MA and 4 others. J Exp Orthop, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Adjuvant injection therapies following knee cartilage repair demonstrate heterogeneous evidence: A systematic review. Papers, record 41245709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41245709

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adjuvant injection therapies following knee cartilage repair demonstrate heterogeneous evidence: A systematic review.
PubMed
Journal
J Exp Orthop
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saráchaga Mendoza MAMax Alfredohttps://orcid.org/0009-0004-0559-9988
2Niemeyer PPhilipp
3Bumberger AAlexanderhttps://orcid.org/0000-0001-9438-0718
4Angele PPeter
5Roessler PPPhilip Phttps://orcid.org/0000-0002-1574-0111

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126585585Adipose-Derived Mesenchymal Stem Cells With Microfracture Versus Microfracture Alone: 2-Year Follow-up of a Prospective Randomized Trial.Arthroscopy2016https://conductscience.org/library/papers/26585585PubMed
233010756BioCartilage augmentation of marrow stimulation procedures for cartilage defects of the knee: Two-year clinical outcomes.Knee2020https://conductscience.org/library/papers/33010756PubMed
328002899Intraoperative application Platelet rich fibrin, postoperative injections OF PRP or microfracture only for osteochondral lesions of the knee: a five-year retrospective evaluation.J Biol Regul Homeost Agents2016https://conductscience.org/library/papers/28002899PubMed
426922057Chondral and osteochondral operative treatment in early osteoarthritis.Knee Surg Sports Traumatol Arthrosc2016https://conductscience.org/library/papers/26922057PubMed
532106760Biological resurfacing of grade IV articular cartilage ulcers in knee joint with Hyalofast.J Orthop Surg (Hong Kong)2020https://conductscience.org/library/papers/32106760PubMed
638572391Treatment of knee cartilage lesions in 2024: From hyaluronic acid to regenerative medicine.J Exp Orthop2024https://conductscience.org/library/papers/38572391PubMed
738436492The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma).Knee Surg Sports Traumatol Arthrosc2024https://conductscience.org/library/papers/38436492PubMed
837568400The Efficacy of Platelet-Rich Plasma Augmentation in Microfracture Surgery Osteochondral Lesions of the Talus: A Systematic Review and Meta-Analysis.J Clin Med2023https://conductscience.org/library/papers/37568400PubMed
935396606Fixation of platelet-rich plasma and fibrin gels on knee cartilage defects after microfracture with arthroscopy.Int Orthop2022https://conductscience.org/library/papers/35396606PubMed
1037109300
The Efficacy of Microfracture Combined with Extracorporeal Shock Wave Therapy for Treating Osteochondral Lesion of the Talus and the Quality of Regenerated Cartilage: A Retrospective Cohort Study and MRI Assessment.
J Clin Med2023https://conductscience.org/library/papers/37109300PubMed
1134528456Current Trends in Orthobiologics: An 11-Year Review of the Orthopaedic Literature.Am J Sports Med2022https://conductscience.org/library/papers/34528456PubMed
1238164688An Update on Orthobiologics: Cautious Optimism.Am J Sports Med2024https://conductscience.org/library/papers/38164688PubMed
1335366851Hyaluronic acid as an adjunct to microfracture in the treatment of osteochondral lesions of the talus: a systematic review of randomized controlled trials.BMC Musculoskelet Disord2022https://conductscience.org/library/papers/35366851PubMed
1438679437Conservative Treatment for Ankle Cartilage: Cellular and Acellular Therapies: A Systematic Review.Foot Ankle Clin2024https://conductscience.org/library/papers/38679437PubMed
1525606529The treatment of chondral lesions of the knee with the microfracture technique and platelet-rich plasma.Joints2013https://conductscience.org/library/papers/25606529PubMed
1625035819Cartilage repair techniques of the talus: An update.World J Orthop2014https://conductscience.org/library/papers/25035819PubMed
1732990794Leucocyte-poor-platelet-rich plasma intra-operative injection in chondral knee injuries improve patients outcomes. A prospective randomized trial.Int Orthop2021https://conductscience.org/library/papers/32990794PubMed
1838309989Arthroscopic microfracture and associated techniques in the treatment of osteochondral lesions of the talus: A systematic review and metanalysis.Foot Ankle Surg2024https://conductscience.org/library/papers/38309989PubMed
1931312692
Transplantation of autologous bone marrow-derived mesenchymal stem cells under arthroscopic surgery with microfracture versus microfracture alone for articular cartilage lesions in the knee: A multicenter prospective randomized control clinical trial.
Regen Ther2019https://conductscience.org/library/papers/31312692PubMed
2037730459Microfracture surgery combined with platelet-rich plasma injection in treating osteochondral lesions of talus: A system review and update meta analysis.Foot Ankle Surg2024https://conductscience.org/library/papers/37730459PubMed

See all 59 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42255387Combined ultrasound-guided hyaluronic acid injections, high-power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial.J Exp Orthop2026https://conductscience.org/library/papers/42255387PubMed
41245709Adjuvant injection therapies following knee cartilage repair demonstrate heterogeneous evidence: A systematic review.J Exp Orthop2025https://conductscience.org/library/papers/41245709PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41245709

GET https://conductscience.org/api/papers/v1/41245709/references?page=2